Clinical Trial Update: Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% [Phase 2]

View source ↗

Summary

Phase 2 trial of MRX-6 Cream 2% for atopic dermatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• MRX-6 Cream 2% (MRX-6 Cream)

Snippet

Sponsor: Celsus Therapeutics PLC | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED